Norwalk virus, also known as Norovirus, is a common intestinal virus that can cause acute gastroenteritis. In recent years, Norwalk virus has been one of the main pathogens causing human gastrointestinal diseases, especially in cold seasons and in enclosed environments where the virus can easily spread.
Globally, millions of people are infected with Norwalk virus-induced gastroenteritis every year, with children and the elderly being particularly susceptible to infection. Therefore, the prevention and control of Norwalk virus infection has always been an important part of public health work.
This article will elaborate on several aspects of the Norwalk virus, including its structure, pathogenic mechanism, transmission routes, and prevention and control.
1. Virus Structure
Norwalk virus is a small, non-enveloped, single-stranded RNA virus belonging to the Caliciviridae family and is a common intestinal virus. It is a spherical virus with a diameter of approximately 27-38 nanometers, and has protruding structures on its surface. These protruding structures play an important role in the structure and function of the virus, helping the virus to bind and enter host cells.
The outer shell structure of Norwalk virus is composed of 90 VP1 molecules and 60 VP2 molecules, forming 60 icosahedral (T=3) structures . Both VP1 and VP2 proteins have important immunogenicity, and can induce the human immune system to produce antibodies, thus playing a protective role.
In addition, there are other non-structural proteins in Norwalk virus, such as VPg and NS1-2, which play important roles in the virus replication and infection process . The most important of these are the RNA-dependent RNA polymerase (RdRp) and the protease 3C (3Cpro). RdRp is the core enzyme in the replication process of Norwalk virus, and can replicate RNA templates into new RNA molecules. 3Cpro is an important protease in the replication process of Norwalk virus, which can cleave and process a large number of protein precursors to produce mature virus proteins.
2. The Infectivity and Pathogenesis of Norovirus
Norovirus mainly infects humans, especially children and the elderly. It enters the body through the mouth, usually spread through food or water, and can also be transmitted through contact with the hands of infected individuals. Due to its high infectivity and widespread distribution, norovirus is one of the main pathogens causing acute gastroenteritis globally.
The pathogenesis of norovirus mainly involves infection of intestinal epithelial cells, disrupting the structure and function of the intestines, and leading to symptoms of diarrhea and gastroenteritis, involving the following aspects:
Infection: Norovirus enters the human body through oral ingestion, enters the intestine and infects intestinal epithelial cells.
Virus replication: Norovirus enters intestinal epithelial cells by binding to receptors on their surface, and replicates viral particles inside the cells, leading to cell death or damage.
Immune response: After infection with norovirus, the immune system releases inflammatory mediators and antibodies, among other immune cells, to fight the virus. These immune cells may cause intestinal inflammation and edema.
Diarrhea: Norovirus infection of intestinal epithelial cells can cause intestinal dysfunction, leading to an imbalance of water and electrolytes in the intestine, resulting in symptoms such as diarrhea.
Neural regulation: Norovirus infection may interfere with the normal function of the intestinal nervous system, leading to abnormal intestinal motility and gastroenteric spasms.
Intestinal microbiota: Norovirus infection may disrupt the balance of intestinal microbiota, reducing the number of beneficial bacteria and increasing harmful bacteria, leading to dysbiosis.
In summary, norovirus is highly infectious, and its pathogenesis involves multiple factors, including infection, virus replication, immune response, neural regulation, and intestinal microbiota, which together lead to the occurrence of symptoms such as diarrhea and gastroenteritis.
3. Prevention and Treatment of Norwalk Virus
The transmission routes of Norwalk virus include food, water, and contact, among others. In order to prevent and control the infection of Norwalk virus, the following measures need to be taken:
Maintain hand hygiene: Norwalk virus can be transmitted through contact with infected hands, so it is very important to maintain hand hygiene, including frequent hand washing and the use of disinfectants.
Pay attention to food hygiene: Norwalk virus is usually spread through food or water, so food hygiene is also a key factor in preventing infection, such as avoiding the consumption of raw seafood and fruits and vegetables.
Strengthen personal immunity: Strengthening physical exercise, maintaining regular work and rest, having a balanced diet, and enhancing the body's immune system can help prevent infection.
The treatment of Norwalk virus mainly involves symptomatic treatment, including fluid supplementation, maintaining water and electrolyte balance, and antibiotic treatment. As there are currently no specific drugs available for the direct treatment of Norwalk virus infection, symptomatic treatment is currently the most effective treatment method.
4. Progress in the Research of Norovirus Vaccine
As the research on Norwalk virus continues to deepen, scientists are searching for effective vaccines and treatments to prevent and treat Norwalk virus infections . Currently, the vaccines under investigation include oral vaccines and genetic engineering vaccines.
Oral vaccine: This vaccine utilizes genetic engineering technology to express the Norwalk virus capsid protein in yeast or insect cells, producing Norwalk virus-like particles. Early clinical trial results show that it can induce the human immune system to produce antibodies, but its protective effect requires further research .
Genetic engineering vaccine: This vaccine utilizes genetic engineering technology to inject Norwalk virus genetic material into non-pathogenic bacteria or viruses, producing a genetic engineering vaccine. There is currently no clinical trial result regarding this vaccine .
In summary, the development of Norwalk virus vaccine is still in its early stages, and further research and experimentation are needed to determine its safety and effectiveness.
5. CUSABIO offers various products that are useful for Norwalk virus research
CUSABIO offers Norwalk virus capsid protein-related products that can assist researchers in gaining deeper insights into the structure, infection mechanisms, and immunological characteristics of the Norwalk virus. This can provide more effective means for the prevention and treatment of the disease.
 Prasad, B. V.,et al. (1999). X-ray crystallographic structure of the Norwalk virus capsid. Science, 286(5438), 287-290.
 Mutations within the P2 domain of norovirus capsid affect binding to human histo-blood group antigens: evidence for a binding pocket. Journal of virology, 77(22), 12562-12571.
 Atmar, R. L.,et al. (2011). Norovirus vaccine against experimental human Norwalk virus illness. New England Journal of Medicine, 365(23), 2178-2187.
 Chen, X.,et al. (2012). Norovirus P particle, a novel platform for vaccine development and antibody production. Journal of virology, 86(6), 3219-3227.
 Lindesmith, L. C.,et al. (2015). Broad blockade antibody responses in human volunteers after immunization with a multivalent Norovirus VLP candidate vaccine.
CUSABIO team. Norwalk Virus. https://www.cusabio.com/c-21111.html